CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Oasmia Pharmaceutical AB Company Snapshot
Oasmia Pharmaceutical AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oasmia Pharmaceutical AB with three other pharmaceutical manufacturers in Europe: Immunodiagnostic System HDQ of UNITED KINGDOM (2020 sales of £39.35 million [US$49.62 million] of which 59% was Automated), Worldwide Healthcare Trust Plc of UNITED KINGDOM (£11.02 million [US$13.90 million] ), and Medincell SA which is based in FRANCE (2.85 million Euros [US$3.23 million] ).

Sales Analysis. Sales increased substantially in 2020: Oasmia Pharmaceutical AB reported sales of SEK 201.84 million (US$21.93 million) for the fiscal year ending April of 2020. This represents an increase of 10,094.1% versus 2019, when the company's sales were SEK 1.98 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Oasmia Pharmaceutical AB
  Stock Performance Chart for Oasmia Pharmaceutical AB
 
  Stock Data: Recent Stock Performance:
  Current Price (7/10/2020): 5.23
(Figures in Swedish Kronor)
1 Week 0.0%   13 Weeks -15.0%  
4 Weeks -27.4%   52 Weeks 1.5%  
 
Oasmia Pharmaceutical AB Key Data:
  Ticker: OASM Country: Sweden
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 201,843,000
(Year Ending Jan 2021).
Employees: 60
  Currency: Swedish Kronor Market Cap: 2,342,733,250
  Fiscal Yr Ends: April Shares Outstanding: 448,370,000
  Share Type: Closely Held Shares: 174,286,538
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.